Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Treatment and Outcomes of Ewing Sarcoma in Turkish Adults: A Single Centre Experience

  • Seker, Mehmet Metin (Department of Medical Oncology, Cumhuriyet University Medical Faculty) ;
  • Kos, Tugba (Department of Medical Oncology, Manisa State Hospital) ;
  • Ozdemir, Nuriye (Department of Medical Oncology, Numune Education and Research Hospital) ;
  • Seker, Ayse (Department of Medical Oncology, Mutki State Hospital) ;
  • Aksoy, Sercan (Department of Medical Oncology, Hacettepe University Cancer Institute) ;
  • Uncu, Dogan (Department of Medical Oncology, Numune Education and Research Hospital) ;
  • Zengin, Nurullah (Department of Medical Oncology, Numune Education and Research Hospital)
  • Published : 2014.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Ewing sarcoma is a small round cell tumor arising from soft tissue and bone that predominantly affects children and adolescents. The most unfavorable prognostic factor is the presence of distant metastasis at the time of diagnosis. Materials and Methods: The records of 26 Ewing sarcoma patients (14 male, 12 female) were re-evaluated retrospectively. Results: The median age was 26.5 (19-42) years. Eight patients (31%) showed a primary tumor in their extremities, 8 (31%) in the thorax, 4 (15%) at the vertebra, 4 (15%) in the head and neck, and 2 (8%) in the abdomen. Five patients (19%) had distant metastasis at diagnosis. The median progression-free survival was 72 months and 10 months in localized and metastatic disease, respectively (p=0.005). The overall survival rate was 19 months in metastatic disease, and the 5-year overall survival rate was 64% in localized disease (p=0.006). Patients who had localized disease in the extremities and were under age 30 had a favorable prognosis. Conclusions: Although Ewing sarcoma is a tumor affecting children and adolescents, it may be seen in adults, where the prognosis is generally worse. Although it is a highly malignant tumor, it is possible to achieve improved survival with combined modality treatments.

Keywords

References

  1. Applebaum MA, Worch J, Matthay KK, et al (2011). Clinical features and outcomes in patients with extraskeletal Ewing sarcoma. Cancer, 117, 3027-32. https://doi.org/10.1002/cncr.25840
  2. Bacci G, Dallari D, McDonald D, et al (1989). Neoadjuvant chemotherapy for localized Ewing's sarcoma of the extremities: preliminary results of a protocol which uses surgery (alone or followed by radiotherapy) for local control. Tumori, 75, 456-62.
  3. Bacci G, Ferrari S, Comandone A, et al (2000). Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine years. Acta Oncol, 39, 111-6. https://doi.org/10.1080/028418600431076
  4. Balamuth N J, Womer RB (2010). Ewing's sarcoma. Lancet Oncol, 11, 184-92. https://doi.org/10.1016/S1470-2045(09)70286-4
  5. Baldini, EH, Demetri GD, Fletcher CD, et al (1999). Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome. Ann Surg, 230, 79-86. https://doi.org/10.1097/00000658-199907000-00012
  6. Barbieri E, Emiliani E, Zini G, et al (1990). Combined therapy of localized Ewing's sarcoma of bone: analysis of results in 100 patients. Int J Radiat Oncol Biol Phys, 19, 1165-70. https://doi.org/10.1016/0360-3016(90)90223-7
  7. Collier AB, 3rd Simpson L, Monteleone P (2011). Cutaneous Ewing sarcoma: report of 2 cases and literature review of presentation, treatment, and outcome of 76 other reported cases. J Pediatr Hematol Oncol, 33, 631-4. https://doi.org/10.1097/MPH.0b013e31821b234d
  8. Cotterill SJ, Ahrens S, Paulussen M, et al (2000). Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol, 18, 3108-14.
  9. Fizazi K, Dohollou N, Blay JY, et al (1998). Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients. J Clin Oncol, 16, 3736-43.
  10. Granowetter L, Womer R, Devidas M, et al (2009). Doseintensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. J Clin Oncol, 27, 2536-41. https://doi.org/10.1200/JCO.2008.19.1478
  11. Grier HE, Krailo MD, Tarbell NJ, et al (2003). Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med, 348, 694-701. https://doi.org/10.1056/NEJMoa020890
  12. Gupta AA, Pappo A, Saunders N, et al (2010). Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy. Cancer, 116, 3189-94. https://doi.org/10.1002/cncr.25144
  13. Iwamoto Y (2007). Diagnosis and treatment of Ewing's sarcoma. Jpn J Clin Oncol, 37, 79-89. https://doi.org/10.1093/jjco/hyl142
  14. Juergens H, Daw NC, Geoerger B, et al (2011). Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma. J Clin Oncol, 29, 4534-40. https://doi.org/10.1200/JCO.2010.33.0670
  15. Jurgens, H, U Dirksen (2011). Ewing sarcoma treatment. Eur J Cancer, 47, 366-7.
  16. Jurgens H, Exner U (1988). Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer, 61, 23-32. https://doi.org/10.1002/1097-0142(19880101)61:1<23::AID-CNCR2820610106>3.0.CO;2-M
  17. Kolb EA, Kushner BH, Gorlick R, et al (2003). Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. J Clin Oncol 21, 3423-30. https://doi.org/10.1200/JCO.2003.10.033
  18. Kushner BH, Meyers PA (2001). How effective is dose-intensive/ myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. J Clin Oncol, 19, 870-80.
  19. Obata H, Ueda T, Kawai A, et al (2007). Clinical outcome of patients with Ewing sarcoma family of tumors of bone in Japan: the Japanese Musculoskeletal Oncology Group cooperative study. Cancer, 109, 767-75. https://doi.org/10.1002/cncr.22481
  20. Oberlin O, Deley MC, Bui BN, et al (2001). Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer, 85, 1646-54. https://doi.org/10.1054/bjoc.2001.2150
  21. Saeter G (2007). Ewing's sarcoma of bone: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol, 18, 79-80.
  22. Schwartz GK, Tap WD, Qin LX, et al (2013). Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial. Lancet Oncol, 14 371-82. https://doi.org/10.1016/S1470-2045(13)70049-4
  23. Scurr M, Judson I (2006). How to treat the Ewing's family of sarcomas in adult patients. Oncologist, 11, 65-72. https://doi.org/10.1634/theoncologist.11-1-65
  24. Shannon Orr W, Denbo JW, Billups CA, et al (2012). Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience. Ann Surg Oncol, 19, 3816-22. https://doi.org/10.1245/s10434-012-2458-4
  25. Subbiah V, Anderson P, Lazar AJ, et al (2009). Ewing's sarcoma: standard and experimental treatment options. Curr Treat Options Oncol, 10, 126-40. https://doi.org/10.1007/s11864-009-0104-6
  26. Tap WD, Demetri G, Barnette P, et al (2012). Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors. J Clin Oncol, 30, 1849-56. https://doi.org/10.1200/JCO.2011.37.2359
  27. van Doorninck JA, Ji L, Schaub B, et al (2010). Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol, 28, 1989-94. https://doi.org/10.1200/JCO.2009.24.5845

Cited by

  1. Survival of Patients with Ewing's Sarcoma in Yazd-Iran vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.4861
  2. A case of small bowel metastasis from spinal Ewing sarcoma causing intussusception in an adult female vol.14, pp.1, 2016, https://doi.org/10.1186/s12957-016-0850-4
  3. Prognosis and Outcome of Adult Patients with Ewing Sarcoma (Local Experience) vol.08, pp.08, 2017, https://doi.org/10.4236/jct.2017.88066